
Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Newsletters and Deep Dive digital magazine
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.
Developments in the oncology space in 2024 brought hope to both industry and patients.
In a new white paper from Altmetric – ‘The changing landscape of journal performance measurement’ – learn how publication planners and medical affairs communications teams can leverage the
Artificial intelligence (AI) has long promised to transform the life sciences, but today, we stand at a critical juncture where this potential is rapidly becoming a reality.
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks